PD-L1 expression in breast cancer brain metastases

BACKGROUND: To evaluate the potential intracranial efficacy of immunotherapy among patients with breast cancer brain metastases (BrM), we analyzed the immunohistochemical expression of programmed death-ligand 1 (PD-L1), a predictive biomarker of response to immunotherapy. METHODS: In this single-cen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chehade, Rania, Qazi, Maleeha A, Ennis, Marguerite, Sahgal, Arjun, Das, Sunit, Nofech-Mozes, Sharon, Jerzak, Katarzyna J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587695/
https://www.ncbi.nlm.nih.gov/pubmed/36299795
http://dx.doi.org/10.1093/noajnl/vdac154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587695/
https://www.ncbi.nlm.nih.gov/pubmed/36299795
http://dx.doi.org/10.1093/noajnl/vdac154

Ejemplares similares